Delayed cutaneous hypersensitivity testing in untreated Hodgkin's disease using a standardized new device

Area of Science:

• Immunology
• Oncology
• Clinical Medicine

Background:

• Hodgkin's disease is a malignancy of the lymphatic system.
• Cell-mediated immunity plays a crucial role in controlling infections and malignancies.
• Assessing immune function in cancer patients is vital for understanding disease progression and treatment outcomes.

Purpose of the Study:

• To evaluate cell-mediated immunity in patients with untreated Hodgkin's disease.
• To determine the prevalence and pattern of delayed cutaneous hypersensitivity (DCH) defects in this patient population.

Main Methods:

• Standardized skin testing with 7 recall antigens was performed.
• 32 patients with untreated Hodgkin's disease were assessed.
• Anergy (lack of response) and hypoergy (reduced response) were recorded.

Main Results:

• A significant proportion of patients (59%) exhibited DCH defects.
• 15 out of 32 patients showed anergy to all tested antigens.
• 4 out of 32 patients displayed hypoergy.

Conclusions:

• Patients with untreated Hodgkin's disease frequently present with impaired DCH responses.
• Immune deficiency was observed across all disease stages and types.
• A trend towards more severe defects was noted in less favorable disease forms and in female patients.